We are live on ! Find out more
VFA

Virtus Fund Advisers Portfolio holdings

AUM $32.1M
1-Year Est. Return 39.5%
This Fund
S&P 500
This Quarter Est. Return
+5.84%
1 Year Est. Return
+39.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$10.2B
AUM Growth
+$370M
Cap. Flow
-$141M
Cap. Flow %
-1.39%
Top 10 Hldgs %
14%
Holding
622
New
136
Increased
89
Reduced
249
Closed
24

Top Buys

Rank Stock Value
1
RSG icon
Republic Services
RSG
+$92.7M
2
FRC
First Republic Bank
FRC
+$73.7M
3
BP icon
BP
BP
+$67.2M
4
KHC icon
Kraft Heinz
KHC
+$62.4M
5
HUM icon
Humana
HUM
+$56.3M

Sector Composition

Rank Sector Weight
1 Financials 16.41%
2 Industrials 15.8%
3 Healthcare 10.6%
4 Technology 10.4%
5 Energy 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTPH
376
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$376K ﹤0.01%
+2,982
New +$382K
STX icon
377
Seagate
STX
$181B
$374K ﹤0.01%
8,816
STML
378
DELISTED
Stemline Therapeutics, Inc.
STML
$374K ﹤0.01%
+23,958
New +$320K
BOLD
379
DELISTED
Audentes Therapeutics, Inc
BOLD
$372K ﹤0.01%
+11,898
New +$327K
GBT
380
DELISTED
Global Blood Therapeutics, Inc.
GBT
$369K ﹤0.01%
+9,390
New +$351K
ALDR
381
DELISTED
Alder Biopharmaceuticals
ALDR
$368K ﹤0.01%
+32,153
New +$359K
MPWR icon
382
Monolithic Power Systems
MPWR
$56.9B
$365K ﹤0.01%
3,243
-274
-8% -$31.8K
ONC
383
BeOne Medicines Ltd
ONC
$39.9B
$365K ﹤0.01%
+3,733
New +$342K
PTCT icon
384
PTC Therapeutics
PTCT
$5.52B
$363K ﹤0.01%
+21,752
New +$368K
MMM icon
385
3M
MMM
$83.3B
$362K ﹤0.01%
1,837
ASMB icon
386
Assembly Biosciences
ASMB
$590M
$361K ﹤0.01%
+665
New +$301K
MRTX
387
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$361K ﹤0.01%
+19,786
New +$307K
SAGE
388
DELISTED
Sage Therapeutics
SAGE
$360K ﹤0.01%
+2,187
New +$212K
JUNO
389
DELISTED
Juno Therapeutics, Inc.
JUNO
$359K ﹤0.01%
+7,860
New +$392K
INSM icon
390
Insmed
INSM
$27B
$358K ﹤0.01%
+11,494
New +$340K
MCRB icon
391
Seres Therapeutics
MCRB
$47.5M
$358K ﹤0.01%
+1,765
New +$363K
PRTA icon
392
Prothena Corp
PRTA
$449M
$358K ﹤0.01%
+9,552
New +$486K
XNCR icon
393
Xencor
XNCR
$1.81B
$358K ﹤0.01%
+16,314
New +$354K
KPTI icon
394
Karyopharm Therapeutics
KPTI
$35.8M
$355K ﹤0.01%
+2,465
New +$396K
SGMO
395
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$354K ﹤0.01%
+21,591
New +$321K
ALNY icon
396
Alnylam Pharmaceuticals
ALNY
$32.9B
$353K ﹤0.01%
+2,775
New +$349K
FELE icon
397
Franklin Electric
FELE
$4.28B
$353K ﹤0.01%
7,687
-652
-8% -$29.4K
CBIO
398
Crescent Biopharma
CBIO
$743M
$352K ﹤0.01%
+210
New +$278K
OLN icon
399
Olin
OLN
$1.92B
$352K ﹤0.01%
9,890
-840
-8% -$29.9K
MB
400
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
$352K ﹤0.01%
11,544
-980
-8% -$30.2K

Similar funds

Virtus Fund Advisers's Q4 2017 Portfolio in Review

As of Q4 2017, Virtus Fund Advisers held 622 positions worth $10.2B, up 3.8% from $9.81B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Virtus Fund Advisers's Q4 2017 filing shows 136 new, 89 increased, 249 reduced and 24 closed positions. Its largest new stake was BP: 1,855,977 shares worth $71.4M. The largest sale was Edison International, an estimated $74.9M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.

  • Virtus Fund Advisers's largest Q4 2017 buy was BP: 1,855,977 shares worth $71.4M.
  • Virtus Fund Advisers added most to Republic Services in Q4 2017, an estimated $92.7M increase.
  • Virtus Fund Advisers's biggest Q4 2017 reduction was Public Storage, cutting an estimated $53.8M.
  • Virtus Fund Advisers fully exited Edison International in Q4 2017, selling an estimated $74.9M.
  • Virtus Fund Advisers's ten largest holdings make up 14% of its $10.2B portfolio in Q4 2017.
  • Virtus Fund Advisers opened 136 new positions and closed 24 in Q4 2017.
  • Virtus Fund Advisers's portfolio value rose 3.8% quarter-over-quarter to $10.2B.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.